Skip to Content

23 Results Found

  • Article
  • Open Access
7 Citations
3,428 Views
7 Pages

Effect of rhTSH on Lipids

  • Alessandro P. Delitala,
  • Angelo Scuteri,
  • Margherita Maioli,
  • Gavino Casu and ,
  • Pierluigi Merella and
  • Giuseppe Fanciulli
  • + 1 author+ 0 author

14 February 2020

Background: Subclinical hypothyroidism is associated with increased blood lipid levels. However, the exact role of thyrotropin (TSH) alone is not clear. In order to clarify this point, we analysed the acute effect of recombinant human TSH (rhTSH) adm...

(This article belongs to the Section Endocrinology & Metabolism)
  • Brief Report
  • Open Access
2 Citations
3,687 Views
8 Pages

Brain [18F]Fluorodeoxyglucose Metabolism Assessment under Hypothyroidism and Recombinant Human Thyroid-Stimulating Hormone in Comparison with Thyroid Hormone Replacement in Patients Submitted to Total Thyroidectomy

  • Sílvia D. Almeida,
  • Francisco P. M. Oliveira,
  • Maria J. Oliveira,
  • José M. Oliveira and ,
  • Rita Afonso,
  • Diogo B. Faria and
  • Durval C. Costa
  • + 2 authors+ 0 author

21 September 2022

Objective: To compare brain metabolism using [18F]fluorodeoxyglucose ([18F]FDG) positron emission tomography/computed tomography (PET/CT) in total thyroidectomy patients during hypothyroidism (levothyroxine withdrawal) or under recombinant human thyr...

(This article belongs to the Section Applied Biosciences and Bioengineering)
  • Article
  • Open Access
4 Citations
2,282 Views
19 Pages

TSH Stimulation before PET/CT as Our Frenemy in Detecting Thyroid Cancer Metastases—Final Results of a Retrospective Analysis

  • Maciej Kołodziej,
  • Marek Saracyn,
  • Arkadiusz Lubas,
  • Dorota Brodowska-Kania and ,
  • Andrzej Mazurek,
  • Mirosław Dziuk,
  • Adam Daniel Durma,
  • Stanisław Niemczyk and
  • Grzegorz Kamiński
  • + 4 authors+ 0 author

8 October 2024

Introduction: Non-iodine avid metastases of differentiated thyroid cancer (DTC) can be found using PET/CT with a fluorine-18-labeled glucose analog ([18F]FDG). There are ongoing discussions on the appropriateness of using exogenous thyrotropin (TSH)...

(This article belongs to the Section Cancer Metastasis)
  • Article
  • Open Access
1,844 Views
10 Pages

31 March 2024

Background: 18F-FDG PET/CT is performed for the assessment of radioactive iodine non-avid disease in patients with DTC. In patients prepared by THW, increased pituitary uptake of 18F-FDG in the absence of pituitary disease may reflect the physiologic...

(This article belongs to the Special Issue PET/CT in Head and Neck Cancer)
  • Article
  • Open Access
2 Citations
2,371 Views
8 Pages

Initial Evaluation of Therapy Response after Adjuvant Radioiodine Therapy in Patients with Early-Stage Papillary Thyroid Cancer—Does Time Matter?

  • Freba Grawe,
  • Yuri Cramm,
  • Matthias P. Fabritius,
  • Johannes Ruebenthaler and ,
  • Viktoria F. Koehler,
  • Harun Ilhan,
  • Peter Bartenstein,
  • Vera Wenter and
  • Andrei Todica
  • + 4 authors+ 0 author

20 January 2022

Background: The aim was to assess ablation success after initial radioiodine (RAI) therapy in early-stage PTC patients and compare outcomes of first diagnostic control after 6 and 9 months (6m/9m-DC) to examine whether time could possibly avoid unnec...

  • Article
  • Open Access
12 Citations
3,581 Views
8 Pages

In Vivo Imaging of Thyroid Cancer with 99mTc-TR1401 and 99mTc-TR1402: A Comparison Study in Dogs

  • Filippo Galli,
  • Michela Varani,
  • Chiara Lauri,
  • Giuseppe Campagna and ,
  • Lajos Balogh,
  • Bruce D. Weintraub,
  • Mariusz W. Szkudlinski,
  • Armando Bartolazzi,
  • Isabella Manni and
  • Alberto Signore
  • + 6 authors+ 1 author

26 April 2021

Differentiated thyroid cancer (DTC) cells may lose NIS expression and iodine uptake, but usually express TSH receptors (TSHR). Therefore, the aim of our study was to compare two radiolabeled superagonist TSH analogues for DTC imaging. These analogues...

(This article belongs to the Section Nuclear Medicine & Radiology)
  • Article
  • Open Access
13 Citations
4,098 Views
9 Pages

Background: this study was designed to compare the long-term survival outcomes of patients prepared for radioiodine (RAI) therapy using either thyroid hormone withdrawal (THW) or recombinant human thyrotropin (rhTSH) stimulation, by specifically focu...

(This article belongs to the Topic Cancer Biology and Therapy)
  • Review
  • Open Access
6 Citations
5,407 Views
12 Pages

15 July 2025

Radioactive iodine (RAI) therapy plays a fundamental role in the management of differentiated thyroid cancer (DTC) following appropriate surgical intervention. High levels of TSH are required in order to achieve maximum RAI uptake in residual thyroid...

(This article belongs to the Section Nuclear Medicine & Radiology)
  • Article
  • Open Access
4 Citations
2,679 Views
13 Pages

The Effect of Recombinant Human TSH on Sclerostin and Other Selected Bone Markers in Patients after Total Thyroidectomy for Differentiated Thyroid Cancer

  • Arkadiusz Zygmunt,
  • Kinga Krawczyk-Rusiecka,
  • Elżbieta Skowrońska-Jóźwiak,
  • Katarzyna Wojciechowska-Durczyńska and ,
  • Ewa Głowacka,
  • Zbigniew Adamczewski and
  • Andrzej Lewiński
  • + 2 authors+ 0 author

24 October 2021

The direct effect of TSH on bone metabolism in vivo is difficult to capture as the changes of its concentrations are followed by respective alterations of thyroid hormone levels. We evaluated the effect of recombinant human TSH (rhTSH) on sclerostin...

(This article belongs to the Special Issue New Insights and Clinical Management of Thyroid Diseases)
  • Article
  • Open Access
2 Citations
2,829 Views
24 Pages

Recombinant Human TSH Fails to Induce the Proliferation and Migration of Papillary Thyroid Carcinoma Cell Lines

  • Georgios Kalampounias,
  • Athina Varemmenou,
  • Christos Aronis,
  • Irene Mamali and ,
  • Athanasios-Nasir Shaukat,
  • Dionysios V. Chartoumpekis,
  • Panagiotis Katsoris and
  • Marina Michalaki
  • + 3 authors+ 0 author

21 July 2024

Thyrotropin (TSH) suppression is required in the management of patients with papillary thyroid carcinoma (PTC) to improve their outcomes, inevitably causing iatrogenic thyrotoxicosis. Nevertheless, the evidence supporting this practice remains limite...

(This article belongs to the Section Molecular Cancer Biology)
  • Review
  • Open Access
20 Citations
5,735 Views
17 Pages

27 April 2023

Background. Differentiated thyroid carcinoma (DTC) is characterized by an excellent prognosis with a 10-year survival rate > 90%. However, when DTC develops in a metastatic form, it has been shown to significantly impact patient survival and quali...

(This article belongs to the Special Issue Thyroid Cancer: New Advances from Diagnosis to Therapy)
  • Interesting Images
  • Open Access
260 Views
4 Pages

TSH Stimulation Reveals Additional Bone Metastases on [18F]FDG PET/CT in Metastatic Follicular Thyroid Carcinoma

  • Jang Bae Moon,
  • Sang-Geon Cho,
  • Sae-Ryung Kang,
  • Jahae Kim and ,
  • Seong-Young Kwon and
  • Su Woong Yoo
  • + 1 author+ 0 author

28 September 2026

A 62-year-old woman with metastatic follicular thyroid carcinoma underwent 2-deoxy-2-[18F]fluoro-D-glucose ([18F]FDG) PET/CT before a second course of radioactive iodine therapy because of a markedly elevated serum thyroglobulin level (498.0 ng/mL)....

(This article belongs to the Special Issue PET/CT Imaging in Oncology: Clinical Advances and Perspectives)
  • Article
  • Open Access
4 Citations
5,461 Views
10 Pages

Absorbed Dose Evaluation in Radioiodine Therapy with Different Approaches

  • Stefania Mazzaglia,
  • Giuseppe Stella,
  • Letizia Barone Tonghi,
  • Cristina N. Tuvé and ,
  • Giuseppe Politi,
  • Gabriella Pellegriti and
  • Anna M. Gueli
  • + 2 authors+ 0 author

The main approach to differentiated thyroid cancer (DTC) therapy is still empiric, consisting of the administration of fixed activities. Repeated treatments, however, may have a stunning effect. An individualized dosimetric study may represent an imp...

  • Article
  • Open Access
9 Citations
4,609 Views
13 Pages

24 October 2024

Despite the generally good prognosis of differentiated thyroid cancer (DTC), impairments in health-related quality of life (HRQoL) remain a major concern in these patients. This study examined the patterns and predictors of change in mental and physi...

(This article belongs to the Section Psychosocial Oncology)
  • Article
  • Open Access
1 Citations
2,500 Views
9 Pages

(1) Background: After thyroid malignancy is ruled out, treatment options for multinodular goiter patients include surgery, levothyroxine suppressive therapy, and 131-I therapy. Surgery effectively reduces goiter size but carries risks of surgical and...

(This article belongs to the Section Clinical Laboratory Medicine)
  • Review
  • Open Access
40 Citations
11,831 Views
21 Pages

Radio-Iodide Treatment: From Molecular Aspects to the Clinical View

  • Antonio De la Vieja and
  • Garcilaso Riesco-Eizaguirre

27 February 2021

Thyroid radio-iodide therapy (RAI) is one of the oldest known and used targeted therapies. In thyroid cancer, it has been used for more than eight decades and is still being used to improve thyroid tumor treatment to eliminate remnants after thyroid...

(This article belongs to the Special Issue Advances in Thyroid Carcinoma)
  • Protocol
  • Open Access
1,275 Views
11 Pages

Treatment with Kinase Inhibitors Plus Myo-Inositol as Re-Differentiating Agents in Iodine-Refractory Thyroid Cancers

  • Carlotta Giani,
  • Michele Russo,
  • Paola Lapi,
  • Maria Antonietta Profilo and ,
  • Raffaella Forleo,
  • Barbara Mazzi,
  • Arianna Ghirri,
  • Lisa Caresia,
  • Alfredo Campennì and
  • Daniele Barbaro
  • + 10 authors+ 5 authors

28 February 2026

Background and aim: Recent preclinical studies have confirmed that inhibiting the MAP kinase pathway can induce the re-differentiation of radioiodine (RAI)-refractory (RAIR) follicular cell thyroid cancers (TCs). The aim of this trial is to investiga...

(This article belongs to the Special Issue Research and Management of Endocrine Tumors)
  • Article
  • Open Access
5 Citations
3,072 Views
15 Pages

Oldie but Goldie: The Fundamental Role of Radioiodine in the Management of Thyroid Cancer

  • Alfredo Campennì,
  • Massimiliano Siracusa and
  • Rosaria Maddalena Ruggeri

25 October 2024

Background/Objectives: The management of differentiated thyroid cancer (DTC) patients has undergone a major paradigm shift in past years, especially regarding the role of a careful postoperative disease assessment both in deciding for or against the...

(This article belongs to the Special Issue Thyroid Disease: Updates from Diagnosis to Treatment)
  • Review
  • Open Access
5 Citations
900 Views
9 Pages

1 September 2009

Background: Standard treatment for differentiated thyroid cancer is thyroidectomy followed in selected cases by radioiodine ablation (ra). Recombinant humanized thyroid-stimulating hormone (rhtsh) is an exogenous source of tsh that can be administere...

  • Feature Paper
  • Article
  • Open Access
13 Citations
4,938 Views
9 Pages

Decreased Thyroxine Levels during rhGH Therapy in Children with Growth Hormone Deficiency

  • Ewelina Witkowska-Sędek,
  • Anna Małgorzata Kucharska,
  • Małgorzata Rumińska,
  • Monika Paluchowska and
  • Beata Pyrżak

30 October 2021

Background: Hypothyroidism in children leads to growth retardation. However, there is some evidence that recombinant human growth hormone (rhGH) therapy could suppress thyroid function. The most common observation in rhGH-treated patients is a decrea...

(This article belongs to the Special Issue Hypothyroidism: Causes, Effects and Current Treatments)
  • Article
  • Open Access
1 Citations
2,981 Views
14 Pages

Identification of POU1F1 Variants in Vietnamese Patients with Combined Pituitary Hormone Deficiency

  • Ha Thu Nguyen,
  • Khanh Ngoc Nguyen,
  • Tran Minh Dien,
  • Thi Bich Ngoc Can and ,
  • Thi Thanh Ngan Nguyen,
  • Nguyen Thi Kim Lien,
  • Nguyen Van Tung,
  • Nguyen Thi Xuan,
  • Nguyen Thien Tao and
  • Chi Dung Vu
  • + 10 authors+ 5 authors

Hypopituitarism is a condition characterized by the deficiency of several hormones produced by the pituitary gland. Genetic factors play an important role. Variants in the POU1F1 gene are associated with combined pituitary hormone deficiency 1 (CPHD1...

(This article belongs to the Special Issue Exploring Rare Diseases: Genetic, Genomic and Metabolomic Advances)
  • Review
  • Open Access
10 Citations
3,885 Views
47 Pages

4 November 2025

In birds, light can penetrate the cranial bones and reach deep brain regions, where non-visual photoreceptors, especially in the hypothalamus, detect spectral and photoperiodic cues. Alongside retinal photoreception, deep-brain light sensing contribu...

(This article belongs to the Special Issue Enhancing Sustainable Poultry Production: Innovations in Management and Nutrition)
  • Article
  • Open Access
3 Citations
2,805 Views
13 Pages

Possible Involvement of Hypothalamic Dysfunction in Long COVID Patients Characterized by Delayed Response to Gonadotropin-Releasing Hormone

  • Yuki Otsuka,
  • Yoshiaki Soejima,
  • Yasuhiro Nakano,
  • Atsuhito Suyama and ,
  • Ryosuke Takase,
  • Kohei Oguni,
  • Yohei Masuda,
  • Daisuke Omura,
  • Yasue Sakurada and
  • Fumio Otsuka
  • + 10 authors+ 5 authors

Long COVID (LC) may involve endocrine dysfunction; however, the underlying mechanism remains unclear. To examine hypothalamic–pituitary responses in patients with LC, we conducted a single-center retrospective study of patients with refractory...

(This article belongs to the Special Issue The Role of Neuropeptides and Their GPCRs in the Neuroendocrine System)